{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T07:42:12Z","timestamp":1781163732247,"version":"3.54.1"},"reference-count":39,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,3,1]],"date-time":"2012-03-01T00:00:00Z","timestamp":1330560000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmacological and Toxicological Methods"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1016\/j.vascn.2011.12.001","type":"journal-article","created":{"date-parts":[[2011,12,31]],"date-time":"2011-12-31T03:23:35Z","timestamp":1325301815000},"page":"58-63","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Developmental and reproductive toxicity testing of vaccines"],"prefix":"10.1016","volume":"65","author":[{"given":"Paul","family":"Barrow","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vascn.2011.12.001_bb0005","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.reprotox.2009.04.012","article-title":"Juvenile toxicity of cyclosporin in the rat","volume":"28","author":"Allais","year":"2009","journal-title":"Reproductive Toxicology"},{"key":"10.1016\/j.vascn.2011.12.001_bb0010","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.vetimm.2007.03.001","article-title":"Transmission of antibodies from mother to young: Evolutionary strategies in a proteolytic environment","volume":"117","author":"Baintner","year":"2007","journal-title":"Veterinary Immunology and Immunopathology"},{"key":"10.1016\/j.vascn.2011.12.001_bb0015","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.yrtph.2005.06.001","article-title":"Immune assessments in developmental and juvenile toxicology: Practical considerations for the regulatory safety testing of pharmaceuticals","volume":"43","author":"Barrow","year":"2005","journal-title":"Regulatory Toxicology and Pharmacology"},{"key":"10.1016\/j.vascn.2011.12.001_bb0020","series-title":"Nonclinical drug safety assessment: Practical considerations for successful registration","first-page":"411","article-title":"Toxicology testing for products intended for pediatric populations","author":"Barrow","year":"2007"},{"key":"10.1016\/j.vascn.2011.12.001_bb0025","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.reprotox.2009.03.013","article-title":"Reproductive toxicity testing for pharmaceuticals under ICH","volume":"28","author":"Barrow","year":"2009","journal-title":"Reproductive Toxicology"},{"key":"10.1016\/j.vascn.2011.12.001_bb0205","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1080\/10915810801978110","article-title":"What's so special about the developing immune system?","volume":"27","author":"Burns-Naas","year":"2008","journal-title":"International Journal of Toxicology"},{"key":"10.1016\/j.vascn.2011.12.001_bb0035","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1002\/bdrb.20216","article-title":"Developmental and reproductive toxicology studies in nonhuman primates","volume":"86","author":"Chellman","year":"2009","journal-title":"Birth Defects Research. Part B, Developmental and Reproductive Toxicology"},{"key":"10.1016\/j.vascn.2011.12.001_bb0210","unstructured":"Centers for Disease Control and Prevention. Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices. MMWR 48 (1999)."},{"key":"10.1016\/j.vascn.2011.12.001_bb0045","unstructured":"Centers for Disease Control and Prevention. Use of influenza A (H1N1) 2009 monovalent vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR 58 (2009) 1\u20138."},{"key":"10.1016\/j.vascn.2011.12.001_bb0050","unstructured":"Daily Telegraph, (2010). Swine flu vaccine safety probed over link to rare sleep disorder. http:\/\/www.telegraph.co.uk\/health\/healthnews\/7967815\/Swine-flu-vaccine-safety-probed-over-link-to-rare-sleep-disorder.html. Published 27\/08\/10. Consulted 25\/10\/10."},{"key":"10.1016\/j.vascn.2011.12.001_bb0055","series-title":"Immunotoxicity testing: Methods and protocols","first-page":"17","article-title":"Developmental immunotoxicity (DIT): The why, when and how of DIT testing","author":"Dietert","year":"2010"},{"key":"10.1016\/j.vascn.2011.12.001_bb0215","series-title":"Note for guidance on preclinical pharmacological and toxicological testing of vaccines","author":"EMEA","year":"1997"},{"key":"10.1016\/j.vascn.2011.12.001_bb0220","series-title":"Guideline on the need for non-clinical testing in juvenile animals of pharmaceuticals for paediatric indications","author":"EMEA","year":"2008"},{"key":"10.1016\/j.vascn.2011.12.001_bb0225","series-title":"Draft guidance: Considerations for reproductive toxicity studies for preventive vaccines for infectious disease indications","author":"FDA","year":"2000"},{"key":"10.1016\/j.vascn.2011.12.001_bb0230","series-title":"Guidance for industry: Considerations for developmental toxicity studies for preventive and therapeutic vaccines for infectious disease indications","author":"FDA","year":"2006"},{"key":"10.1016\/j.vascn.2011.12.001_bb0235","series-title":"Guidance for industry: Nonclinical safety evaluation of pediatric drug products","author":"FDA","year":"2006"},{"key":"10.1016\/j.vascn.2011.12.001_bb0085","unstructured":"Forster, this issue."},{"key":"10.1016\/j.vascn.2011.12.001_bb0095","doi-asserted-by":"crossref","first-page":"3487","DOI":"10.1016\/S0264-410X(03)00357-8","article-title":"Maternal immunization: US FDA regulatory considerations","volume":"21","author":"Gruber","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vascn.2011.12.001_bb0100","first-page":"427","article-title":"Prenatal and postnatal transmission of passive immunity to young rats","volume":"144","author":"Halliday","year":"1955","journal-title":"Proceedings of the Royal Society of Edinburgh Section B: Biology"},{"key":"10.1016\/j.vascn.2011.12.001_bb0105","first-page":"687","article-title":"Prenatal immunotoxicant exposure and postnatal autoimmune disease","volume":"107","author":"Holladay","year":"1999","journal-title":"Environmental Health Perspectives"},{"key":"10.1016\/j.vascn.2011.12.001_bb0110","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S1567-5769(01)00183-7","article-title":"Maternal immune stimulation in mice decreases fetal malformations caused by teratogens","volume":"2","author":"Holladay","year":"2002","journal-title":"International Immunopharmacology"},{"key":"10.1016\/j.vascn.2011.12.001_bb0115","series-title":"Developmental and reproductive toxicology: A practical approach","first-page":"3","article-title":"Principles of developmental toxicology revisited","author":"Hood","year":"2006"},{"key":"10.1016\/j.vascn.2011.12.001_bb0120","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/toxsci\/kfq242","article-title":"A quarter-century of immunotoxicology: Looking back, looking forward","volume":"118","author":"House","year":"2010","journal-title":"Toxicological Sciences"},{"key":"10.1016\/j.vascn.2011.12.001_bb0245","series-title":"Harmonised Tripartite Guideline S5(R2). Detection of toxicity to reproduction for medicinal products & toxicity to male fertility","author":"ICH","year":"2005"},{"key":"10.1016\/j.vascn.2011.12.001_bb0250","series-title":"Draft consensus guideline. Addendum to ICH S6: Preclinical safety evaluation of biotechnology-derived pharmaceuticals","author":"ICH","year":"2009"},{"key":"10.1016\/j.vascn.2011.12.001_bb0135","series-title":"Developmental immunotoxicity","first-page":"21","article-title":"Development of the human immune system","author":"Leibnitz","year":"2005"},{"key":"10.1016\/j.vascn.2011.12.001_bb0140","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1542\/peds.111.3.653","article-title":"Do vaccines cause allergic or autoimmune diseases?","volume":"111","author":"Offit","year":"2003","journal-title":"Pediatrics"},{"key":"10.1016\/j.vascn.2011.12.001_bb0145","unstructured":"OTIS (2010). http:\/\/www.otispregnancy.org\/vaccines-and-medications-in-pregnancy-surveillance-system-p135759. Consulted 18\/10\/10."},{"key":"10.1016\/j.vascn.2011.12.001_bb0150","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/bdrb.20201","article-title":"An interspecies comparison of placental antibody transfer: New insights into developmental toxicity testing of monoclonal antibodies","volume":"86","author":"Pentsuk","year":"2009","journal-title":"Birth Defects Research. Part B, Developmental and Reproductive Toxicology"},{"key":"10.1016\/j.vascn.2011.12.001_bb0155","series-title":"Immunotoxicity testing: Methods and protocols","first-page":"159","article-title":"The T-dependent antibody response to Keyhole Limpet Hemocyanin in rodents","author":"Plitnick","year":"2010"},{"key":"10.1016\/j.vascn.2011.12.001_bb0160","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/S0167-5699(97)01127-4","article-title":"Th1-type immunity is incompatible with successful pregnancy","volume":"18","author":"Raghupathy","year":"1997","journal-title":"Immunology Today"},{"key":"10.1016\/j.vascn.2011.12.001_bb0165","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S1471-4906(02)02182-8","article-title":"Antifertility vaccines","volume":"23","author":"Roitt","year":"2002","journal-title":"Trends in Immunology"},{"key":"10.1016\/j.vascn.2011.12.001_bb0255","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1002\/bdra.20470","article-title":"Evaluation of preterm births and birth defects in liveborn infants of US military women who received smallpox vaccine","author":"Ryan","year":"2008","journal-title":"Birth Defects Research. Part A, Clinical and Molecular Teratology"},{"key":"10.1016\/j.vascn.2011.12.001_bb0175","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.reprotox.2010.05.019","article-title":"2009 H1N1 vaccination in pregnancy \u2014 Experience of the European network of teratology information services (ENTIS)","volume":"30","author":"Schaefer","year":"2010","journal-title":"Reproductive Toxicology"},{"key":"10.1016\/j.vascn.2011.12.001_bb0180","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.reprotox.2009.04.002","article-title":"Developmental toxicity testing of monoclonal antibodies: An enhanced pre- and postnatal study design option","volume":"28","author":"Stewart","year":"2009","journal-title":"Reproductive Toxicology"},{"key":"10.1016\/j.vascn.2011.12.001_bb0185","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0300-483X(02)00607-8","article-title":"Pregnancy and the immune system: Between tolerance and rejection","volume":"185","author":"Thellin","year":"2003","journal-title":"Toxicology"},{"key":"10.1016\/j.vascn.2011.12.001_bb0190","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S0300-483X(02)00611-X","article-title":"Reproductive toxicity testing of vaccines","volume":"185","author":"Verdier","year":"2003","journal-title":"Toxicology"},{"key":"10.1016\/j.vascn.2011.12.001_bb0195","series-title":"Immunotoxicity testing: Methods and protocols","first-page":"173","article-title":"The sheep erythrocyte T-dependent antibody response (TDAR)","author":"White","year":"2010"},{"key":"10.1016\/j.vascn.2011.12.001_bb0200","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/bdrb.20214","article-title":"Embryo-fetal developmental toxicity study design for pharmaceuticals","volume":"86","author":"Wise","year":"2009","journal-title":"Birth Defects Research. Part B, Developmental and Reproductive Toxicology"}],"container-title":["Journal of Pharmacological and Toxicological Methods"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056871911003224?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1056871911003224?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T23:55:49Z","timestamp":1761004549000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1056871911003224"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["S1056871911003224"],"URL":"https:\/\/doi.org\/10.1016\/j.vascn.2011.12.001","relation":{},"ISSN":["1056-8719"],"issn-type":[{"value":"1056-8719","type":"print"}],"subject":[],"published":{"date-parts":[[2012,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Developmental and reproductive toxicity testing of vaccines","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmacological and Toxicological Methods","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vascn.2011.12.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}